A Guillain-Barre Syndrome-like neuropathy associated with arsenic exposure

Journal of Occupational Health

Volumn 54, Issue 4, 2012, Pages 344-347

  Kim, Sunyoung ^a   Takeuchi, Akito ^b   Kawasumi, Yaeko ^b   Endo, Yoko ^c   Lee, Heun ^a   Kim, Yangho ^a  

^a Ulsan University College of Medicine   (South Korea)

^b JAPAN INDUSTRIAL SAFETY AND HEALTH ASSOCIATION   (Japan)

^c KANSAI ROSAI HOSPITAL   (Japan)

Author keywords

Arsenic; Guillain Barr; Peripheral neuropathy; Species; syndrome

Indexed keywords

PLANT MEDICINAL PRODUCT;

ADULT; ARSENIC POISONING; ARTICLE; CASE REPORT; CHEMICALLY INDUCED DISORDER; DIFFERENTIAL DIAGNOSIS; GUILLAIN BARRE SYNDROME; HUMAN; MALE; PERIPHERAL NEUROPATHY; URINE;

ADULT; ARSENIC POISONING; DIAGNOSIS, DIFFERENTIAL; GUILLAIN-BARRE SYNDROME; HUMANS; MALE; PERIPHERAL NERVOUS SYSTEM DISEASES; PLANT PREPARATIONS;

MLCS; MLOWN;

EID: 84867377703     PISSN: 13419145     EISSN: 13489585     Source Type: Journal    
DOI: 10.1539/joh.12-0023-CS     Document Type: Article

References (15)

1. Greenberg SA. Acute demyelinating polyneuropathy with arsenic ingestion. Muscle Nerve 1996; 19: 1611-3.
2. Heyman A, Pfeiffer JB Jr, Willett RW, Taylor HM. Peripheral neuropathy caused by arsenical intoxication; a study of 41 cases with observations on the effects of BAL (2, 3, dimercapto-propanol). N Engl J Med 1956; 254: 401-9.
3. Jenkins RB. Inorganic arsenic and the nervous system. Brain 1966; 89: 479-98.
4. Vahidnia A, van der Voet GB, de Wolff FA. Arsenic neurotoxicity-a review. Hum Exp Toxicol 2007; 26: 823-32.
5. American Conference of Governmental Industrial Hygienists (ACGIH). Documentation of the Threshold Limit Values and Biological Exposure Indices. 7th Ed. Cincinnati (OH): ACGIH; 2007.
6. Focazio MJ, Welch AH, Watkins SA, Helsel DR, Horn MA. A retrospective analysis on the occurrence of arsenic in ground-water resources of the United States and limitations in drinkingwater-supply-characterizations. Reston (VA): US Geological Survey. Water Resour Invest Rep; 2000. p.99-4279.
7. Cullen WR, Reimer KJ. Arsenic speciation in the environment. Chem Rev 1989; 89: 713-64.
8. Aposhian HV, Aposhian MM. Arsenic toxicology: five questions. Chem Res Toxicol 2006; 19: 1-15.
9. Francesconi KA, Tanggaar R, McKenzie CJ, Goessler W. Arsenic metabolites in human urine after ingestion of an arsenosugar. Clin Chem 2002; 48: 92-101.
10. Hata A, Endo Y, Nakajima Y, et al. HPLC-ICP-MS speciation analysis of arsenic in urine of Japanese subjects without occupational exposure. J Occup Health 2007; 49: 217-23.
11. Suzuki Y, Shimoda Y, Endo Y, Hata A, Yamanaka Y, Endo G. Rapid and effective speciation analysis of arsenic compounds in human urine using anionexchange colomns in HPLC-ICP-MS. J Occup Health 2009; 51: 380-5.
12. Buchet JP, Lauwerys R, Roels H. Urinary excretion of inorganic arsenic and its metabolites after repeated ingestion of sodium metaarsenite by volunteers. Int Arch Occup Environ Health 1981; 48: 111-8.
13. Koh KM. A case of multiple Bowen's disease. Korean J Dermatol 1974; 12: 275-9.
14. Lee HJ, Lee SS, Park SW, Wang HY. Clinical evaluation of arsenical keratosis. Korean J Dermatol 2000; 38: 1461-7.
15. Oh SJ. Electrophysiological profile in arsenic neuropathy. J Neurol Neurosurg Psychiatry 1991; 54: 1103-5.